clinical efficacy and safety of ct-p10 in patients with dlbcl
Published 1 year ago • 41 plays • Length 0:44Download video MP4
Download video MP3
Similar videos
-
3:03
efficacy and safety of vodobatinib by lines of tki therapy in ph cml: a subgroup analysis
-
2:53
comparing the efficacy and safety of ct-p10 to rituximab in advanced stages follicular lymphoma
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
2:25
the safety & efficacy of copanlisib nivolumab in patients with rt and tnhl: a chemo-free approach
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
7:30
updates from juliet: correlative analyses and clinical characteristics associated with efficacy
-
1:34
are thrombotic risk and progression in et predictable?
-
8:57
outcomes of sct in t-all and t-lbl
-
2:41
cell avidity as a predictor of t-cell efficacy
-
1:51
the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll
-
1:38
diagnostic and clinical impact of the revised definition of light chain mgus
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:27
ascembl: asciminib versus bosutinib in third-line treatment of cp-cml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:17
diagnosing rt and identifying patients at risk using ngs and molecular cytogenetic analysis
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml